Previous David Chu Lecture Speakers

Ann E. Weber, PhD, Senior Vice President, Research and Development, Kallyope Inc.
There and Back Again: Therapies for the Treatment of Obesity and Diabetes

George Painter, PhD, Emory University, School of Medicine, CEO of DRIVE (Drug Innovation Ventures at Emory) and Executive Director of The Emory Institute for Drug Development
Developing a Drug in a Pandemic: the Evolution of Molnupiravir as a Treatment

Timothy Heffron, PhD, Senior Director and Head of Oncology/Cancer Immunology Chemistry at Genentech
Considerations in the Discovery of Small Molecule Kinase Inhibitors for the Treatment of Brain Tumors and the Discovery of GDC-0084

Kathleen Hillgren, PhD, Drug Disposition, Lilly Research Laboratories, Indianapolis, IN
Translation of In Vitro Transporter Data into the Clinic

Peter Senter, Vice President of Chemistry at Seattle Genetics, Inc.
Antibody-based therapeutics for cancer therapy: An early stage research to a clinically approved drug

Lisa Benincosa, PhD '93
Evolution of Translational PK/PD: A Pharma Perspective

John Eng, MD
A Drug Discovery

Hank Kung, PhD
Development of Imaging Agents for Diagnosing Alzheimer’s Disease

A. Douglas Kinghorn, PhD
The Enduring Contribution of Natural Products to the Pharmaceutical Sciences

Wolfgang Sadee, PhD
Optimizing Drug Therapy on Person at a Time: How will Pharmacogenomics Succeed

Christopher Lipinski, PhD
Drug Discovery and Chemical Biology: Lessons Learned and Times of Change